VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma
Clinical trial NCT00085696 · COMPLETED
Trial details
- NCT number
- NCT00085696
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2006-04-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.